정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2179 | Recruiting | Antithrombin III in Infectious Disease Caused by COVID-19 | Covid19 | Drug: Antithrombin III | Phase 2 | Enrique Ginzburg, Grifols Biologicals, LLC | OTHER | 75 | All | 18 Years | University of Miami, Miami, Florida, United States |
| 2178 | Completed | Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) | Pneumonia | Drug: Heparin | Phase 3 | University of Manitoba, University Health Network, Toronto | OTHER | 1200 | All | 18 Years | Emory University Hospital Midtown, Atlanta, Georgia, United States University of Chicago, Chicago, Illinois, United States Ochsner Clinic, Jefferson, Louisiana, United States Maine Medical Center, Portland, Maine, United States Henry Ford University, Dearborn, Michigan, United States Beaumont Hospital, Royal Oak, Michigan, United States Mayo Clinic, Rochester, Minnesota, United States Saint Louis University School of Medicine/Saint Louis Veterans Affairs Medical Center, Saint Louis, Missouri, United States Cooper University Health Care, Camden, New Jersey, United States Hackensack University Medical Center, Hackensack, New Jersey, United States Saint Barnabas Medical Center, Livingston, New Jersey, United States Montefiore-Einstein Center for Heart and Vascular Care, New York, New York, United States Vanderbilt University Medical Center, Nashville, Tennessee, United States Santa Casa de Misericordia de Itabuna, Itabuna, BA, Brazil Hospital Unimed do Cariri, Juazeiro do Norte, CE, Brazil Instituto Goiano de Oncologia e Hematologia - INGOH, Goiania, Goias, Brazil Centro de Pesquisas Clinicas Humap - UFMS, Campo Grande, Mato Grosso Do Sul, Brazil Hospital Felicio Rocho, Belo Horizonte, MG, Brazil Clinica de Campo Grande S/A, Campo Grande, MS, Brazil Unimed Campo Grande, Campo Grande, MS, Brazil Hospital Agamenon Magalhaes, Recife, Pernanbuco, Brazil Hospital das Clinicas da UFPR, Curitiba, PR, Brazil Pontificia Universidade Catolica do Parana, Curitiba, PR, Brazil Parana Medical Research Center, Maringa, PR, Brazil Hospital Sao Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil Hospital Universitario Pedro Ernesto, Rio de Janeiro, RJ, Brazil Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil Instituto de Medicina Vascular, Porto Alegre, RS, Brazil AngioCor Blumenau, Blumenau, Santa Catarina, Brazil Instituto de Cardiologia de Santa Catarina, Sao Jose, Santa Catarina, Brazil Instituto de Pesquisa Clinica de Campinas, Campinas, Sao Paulo, Brazil Praxis Pesquisa Medica, Santo Andre, Sao Paulo, Brazil Santa Casa de Votuporanga, Votuporanga, Sao Paulo, Brazil Casa de Saude Santa Marcelina, Sao Paulo, SP, Brazil Instituto de Molestias Cardio Vasculares de Tatui, Tatui, SP, Brazil Hospital 9 de Julho, Sao Paulo, Brazil Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil Instituto de Infectologia Emilio Ribas, Sao Paulo, Brazil Instituto do Coracao do Estado de Sao Paulo, Sao Paulo, Brazil Sociedade Beneficente Israelita Hospital Albert Einstein, Sao Paulo, Brazil Victoria General Hospital, Victoria, British Columbia, Canada Health Sciences Center Winnipeg, Winnipeg, Manitoba, Canada Grace General Hospital, Winnipeg, Manitoba, Canada St. Boniface General Hospital, Winnipeg, Manitoba, Canada Hamilton Health Sciences, Hamilton, Ontario, Canada St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada Hopital Montfort, Ottawa, Ontario, Canada The Ottawa Hospital, Ottawa, Ontario, Canada University Health Network, Toronto, Ontario, Canada McGill University Health Centre, Montreal, Quebec, Canada Centre Hospitalier de l'universite de Montreal (CHUM), Montreal, Quebec, Canada Jewish General Hospital, Montreal, Quebec, Canada CHU de Quebec-University Laval, Quebec, Quebec, Canada Institut universitaire de cardiologie et de pneumologie de Quebec (CRIUCPQ), Quebec, Quebec, Canada Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada Regina General Hospital, Regina, Saskatchewan, Canada Hospital de Infectolog´nia Centro Medico Nacional La Raza, Azcapotzalco, Mexico City, Mexico Hospital General Regional 1 Carlos MacGregor Sanchez Navarro, Benito Juarez, Mexico City, Mexico Hospital General regional 2 El Marques, Queretaro, Mexico |
| 2177 | Completed | Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19) | Covid19 | Drug: Remdesivir Other: Standard of Care |
Phase 2 | Dr. Md. Alimur Reza | INDUSTRY | 60 | All | 18 Years | Combined Military Hospital, Dhaka, Bangladesh |
| 2176 | Recruiting | Antiviral Agents Against COVID-19 Infection | COVID-19 | Drug: Atazanavir Drug: Daclatasvir 60 mg Drug: Sofusbuvir + Daclastavir 60 mg Drug: Placebo Atazanavir Drug: Placebo Daclatasvir 60 mg Drug: Placebo Sofusbuvir + Daclatasvir 60 mg |
Phase 3 | Hospital do Coracao | OTHER | 1005 | All | 18 Years ~ 90 Years | Hospital do Coracao, Sao Paulo, SP, Brazil |
| 2175 | Withdrawn | Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure | COVID-19 | Drug: Tranexamic acid Drug: Placebo |
Phase 3 | University of Alabama at Birmingham | OTHER | 0 | All | 18 Years ~ 80 Years | |
| 2174 | Recruiting | Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients | Kidney Transplant Infection | Drug: Voclosporin Drug: Tacrolimus |
Phase 2 | Leiden University Medical Center, Aurinia Pharmaceuticals Inc. | OTHER | 20 | All | 18 Years | Leiden University Medical Center, Leiden, Netherlands |
| 2173 | Terminated | Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19 | SARS CoV-2 Infection | Other: Water Other: Peroxyl Drug: Periogard Other: Colgate Total Zero |
Phase 2 | University of North Carolina, Chapel Hill, Colgate Palmolive | OTHER | 2 | All | 18 Years ~ 65 Years | Adams School of Dentistry, Chapel Hill, North Carolina, United States |
